Literature DB >> 15242193

Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period.

Mamta Sharma1, Dorine Berriel-Cass, Joseph Baran.   

Abstract

OBJECTIVE: Surgical-site infection (SSI) is a serious and costly complication following coronary artery bypass graft (CABG). We analyzed surgical factors, microbiology, and complications at a 608-bed community teaching hospital to identify opportunities for prevention.
METHODS: All patients undergoing CABG procedures from June 1997 through December 2000 were analyzed. Hospital records and postdischarge surveillance data were reviewed for demographics, surgical information, timing and classification of infection, microbiology, and bacteremic events.
RESULTS: Of 3,443 patients undergoing CABG, sternal SSI developed in 122 (3.5%); 71 (58.2%) were classified as superficial SSI and 51 (41.8%) as deep SSI. Surgical antimicrobial prophylaxis was employed in all cases. On average, infection occurred 21.5 days (range, 4 to 315) after CABG. Most cases were diagnosed on readmission (59%); 20 cases (16%) were identified by postdischarge surveillance. Microbiological data were positive in 109 (89.3%), with a single pathogen implicated in most (86.2%). Gram-positive cocci were most frequently recovered (81%); gram-negative bacilli (17%), gram-positive bacilli (1%), and yeast (1%) were less common. Staphylococcus aureus was the most frequently isolated pathogen (49%). Bacteremia was noted in 22 instances (18%). It was significantly associated with deep SSI (P =. 002) and identified only in S. aureus cases.
CONCLUSIONS: SSI complicated 3.5% of the procedures. S. aureus was implicated in most of the cases and was significantly associated with deep SSI. It was the only pathogen associated with secondary bacteremia. In addition to standard guidelines, targeted methods against S. aureus should help reduce the overall rate of SSI.

Entities:  

Mesh:

Year:  2004        PMID: 15242193     DOI: 10.1086/502423

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  18 in total

1.  Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis.

Authors:  O Friberg; R Svedjeholm; J Källman; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

2.  Efficacy of the novel topical antimicrobial agent PXL150 in a mouse model of surgical site infections.

Authors:  Joakim Håkansson; Camilla Björn; Kerstin Lindgren; Emma Sjöström; Veronika Sjöstrand; Margit Mahlapuu
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

3.  Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.

Authors:  Megan H Nguyen; Samantha J Eells; Jennifer Tan; Corinne T Sheth; Bassam Omari; Margarita Flores; Jeffrey Wang; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

4.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

5.  Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial.

Authors:  Kay Dhadwal; Sharif Al-Ruzzeh; Thanos Athanasiou; Marina Choudhury; Paris Tekkis; Pynee Vuddamalay; Haifa Lyster; Mohamed Amrani; Shane George
Journal:  Heart       Date:  2007-02-19       Impact factor: 5.994

6.  Daptomycin as a possible new treatment option for surgical management of Methicillin-Resistant Staphylococcus aureus sternal wound infection after cardiac surgery.

Authors:  Aron F Popov; Jan D Schmitto; Theodor Tirilomis; Christian Bireta; Kasim O Coskun; Suyog A Mokashi; Alexander Emmert; Martin Friedrich; Christoph H Wiese; Friedrich A Schoendube
Journal:  J Cardiothorac Surg       Date:  2010-08-06       Impact factor: 1.637

Review 7.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model.

Authors:  Y Barnea; S Navon-Venezia; B Kuzmenko; N Artzi; Y Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-14       Impact factor: 3.267

9.  Treatment of gram-positive deep sternal wound infections in cardiac surgery--experiences with daptomycin.

Authors:  Aron F Popov; Jan D Schmitto; Ahmad F Jebran; Christian Bireta; Martin Friedrich; Direndra Rajaruthnam; Kasim O Coskun; Anselm Braeuer; Jose Hinz; Theodor Tirilomis; Friedrich A Schoendube
Journal:  J Cardiothorac Surg       Date:  2011-09-19       Impact factor: 1.637

10.  Multi-centre prospective internal and external evaluation of the Brompton Harefield Infection Score (BHIS).

Authors:  Melissa Rochon; Julian We Jarman; Joseph Gabriel; Lisa Butcher; Carlos Morais; Martin Still; Ishtiaq Ahmed; Mario Petrou; Richard Trimlett; Anthony DeSouza; Rashmi Yadav; Shahzad G Raja
Journal:  J Infect Prev       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.